199 related articles for article (PubMed ID: 28085790)
1. Epidermal Growth Factor-Containing Fibulin-Like Extracellular Matrix Protein 1 (EFEMP1) Acts as a Potential Diagnostic Biomarker for Prostate Cancer.
Shen H; Zhang L; Zhou J; Chen Z; Yang G; Liao Y; Zhu M
Med Sci Monit; 2017 Jan; 23():216-222. PubMed ID: 28085790
[TBL] [Abstract][Full Text] [Related]
2. EFEMP1 as a novel DNA methylation marker for prostate cancer: array-based DNA methylation and expression profiling.
Kim YJ; Yoon HY; Kim SK; Kim YW; Kim EJ; Kim IY; Kim WJ
Clin Cancer Res; 2011 Jul; 17(13):4523-30. PubMed ID: 21571867
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic regulation of EFEMP1 in prostate cancer: biological relevance and clinical potential.
Almeida M; Costa VL; Costa NR; Ramalho-Carvalho J; Baptista T; Ribeiro FR; Paulo P; Teixeira MR; Oliveira J; Lothe RA; Lind GE; Henrique R; Jerónimo C
J Cell Mol Med; 2014 Nov; 18(11):2287-97. PubMed ID: 25211630
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic and prognostic value of serum miR-15a and miR-16-1 expression among egyptian patients with prostate cancer.
Zidan HE; Abdul-Maksoud RS; Elsayed WSH; Desoky EAM
IUBMB Life; 2018 May; 70(5):437-444. PubMed ID: 29522280
[TBL] [Abstract][Full Text] [Related]
5. The value of
Cui G; Shao M; Gu X; Guo H; Zhang S; Lu J; Ma H
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2241-2245. PubMed ID: 31174436
[No Abstract] [Full Text] [Related]
6. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1 (EFEMP1) suppressed the growth of hepatocellular carcinoma cells by promoting Semaphorin 3B(SEMA3B).
Hu J; Duan B; Jiang W; Fu S; Gao H; Lu L
Cancer Med; 2019 Jun; 8(6):3152-3166. PubMed ID: 30972979
[TBL] [Abstract][Full Text] [Related]
7. Evaluating EFEMP1 in Cerebrospinal Fluid and Serum as a Potential Diagnosis Biomarker for Meningiomas.
Jia L; Liu C; Xin Y; Zhang A; Zhou Y; Dong D; Ren L
Clin Lab; 2017 Oct; 63(10):1717-1722. PubMed ID: 29035461
[TBL] [Abstract][Full Text] [Related]
8. Decreased expression of angiogenesis antagonist EFEMP1 in sporadic breast cancer is caused by aberrant promoter methylation and points to an impact of EFEMP1 as molecular biomarker.
Sadr-Nabavi A; Ramser J; Volkmann J; Naehrig J; Wiesmann F; Betz B; Hellebrand H; Engert S; Seitz S; Kreutzfeld R; Sasaki T; Arnold N; Schmutzler R; Kiechle M; Niederacher D; Harbeck N; Dahl E; Meindl A
Int J Cancer; 2009 Apr; 124(7):1727-35. PubMed ID: 19115204
[TBL] [Abstract][Full Text] [Related]
9. Novel tumor-suppressor gene epidermal growth factor-containing fibulin-like extracellular matrix protein 1 is epigenetically silenced and associated with invasion and metastasis in human gastric cancer.
Zhu XJ; Liu J; Xu XY; Zhang CD; Dai DQ
Mol Med Rep; 2014 Jun; 9(6):2283-92. PubMed ID: 24718752
[TBL] [Abstract][Full Text] [Related]
10. A Panel of Biomarkers for Diagnosis of Prostate Cancer Using Urine Samples.
Guo J; Yang J; Zhang X; Feng X; Zhang H; Chen L; Johnson H; Persson JL; Xiao K
Anticancer Res; 2018 Mar; 38(3):1471-1477. PubMed ID: 29491074
[TBL] [Abstract][Full Text] [Related]
11. MiR-145 detection in urinary extracellular vesicles increase diagnostic efficiency of prostate cancer based on hydrostatic filtration dialysis method.
Xu Y; Qin S; An T; Tang Y; Huang Y; Zheng L
Prostate; 2017 Jul; 77(10):1167-1175. PubMed ID: 28617988
[TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1 expression and regulation in uterine leiomyoma.
Marsh EE; Chibber S; Wu J; Siegersma K; Kim J; Bulun S
Fertil Steril; 2016 Apr; 105(4):1070-5. PubMed ID: 26702771
[TBL] [Abstract][Full Text] [Related]
13. Combined serum and EPS-urine proteomic analysis using iTRAQ technology for discovery of potential prostate cancer biomarkers.
Zhang M; Chen L; Yuan Z; Yang Z; Li Y; Shan L; Yin B; Fei X; Miao J; Song Y
Discov Med; 2016 Nov; 22(122):281-295. PubMed ID: 28009970
[TBL] [Abstract][Full Text] [Related]
14. EFEMP1 as a Potential Biomarker for Diagnosis and Prognosis of Osteosarcoma.
Wang Z; Kang J; Lian J; Huang L; Xie W; Zhao D; Ma H; Lin Z
Biomed Res Int; 2020; 2020():5264265. PubMed ID: 32280689
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of miR-129 in peripheral blood mononuclear cells is a diagnostic and prognostic biomarker in prostate cancer.
Xu S; Yi XM; Zhou WQ; Cheng W; Ge JP; Zhang ZY
Int J Clin Exp Pathol; 2015; 8(11):14335-44. PubMed ID: 26823749
[TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis.
Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Qiyong L; Fujii T; Sugimoto H; Takeda S; Nakao A
Ann Surg Oncol; 2010 Mar; 17(3):923-32. PubMed ID: 19898900
[TBL] [Abstract][Full Text] [Related]
17. Expression of PCA3 and PSA genes as a biomarker for differential diagnosis of nodular hyperplasia and prostate cancer.
Coelho FF; Guimarães FL; Cabral WL; Salles PG; Mateo EC; Nogueira e Nogueira LM; Fonseca CE; Gomes KB
Genet Mol Res; 2015 Oct; 14(4):13519-31. PubMed ID: 26535666
[TBL] [Abstract][Full Text] [Related]
18. Spondin-2 (SPON2), a more prostate-cancer-specific diagnostic biomarker.
Qian X; Li C; Pang B; Xue M; Wang J; Zhou J
PLoS One; 2012; 7(5):e37225. PubMed ID: 22615945
[TBL] [Abstract][Full Text] [Related]
19. Zinc α2-glycoprotein as a potential novel urine biomarker for the early diagnosis of prostate cancer.
Katafigiotis I; Tyritzis SI; Stravodimos KG; Alamanis C; Pavlakis K; Vlahou A; Makridakis M; Katafigioti A; Garbis SD; Constantinides CA
BJU Int; 2012 Dec; 110(11 Pt B):E688-93. PubMed ID: 23020913
[TBL] [Abstract][Full Text] [Related]
20. Evaluating serum insulin-like growth factor 1 and insulin-like growth factor binding protein 3 as markers in prostate cancer diagnosis.
Rainato G; Fabricio AS; Zancan M; Peloso L; Dittadi R; Barichello M; Fandella A; Scattoni V; Gion M
Int J Biol Markers; 2016 Jul; 31(3):e317-23. PubMed ID: 26954072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]